KR102249431B1 - Composition for treating alopecia comprising Cocos nucifera extract - Google Patents
Composition for treating alopecia comprising Cocos nucifera extract Download PDFInfo
- Publication number
- KR102249431B1 KR102249431B1 KR1020190069559A KR20190069559A KR102249431B1 KR 102249431 B1 KR102249431 B1 KR 102249431B1 KR 1020190069559 A KR1020190069559 A KR 1020190069559A KR 20190069559 A KR20190069559 A KR 20190069559A KR 102249431 B1 KR102249431 B1 KR 102249431B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- alopecia
- coconut
- composition
- hair loss
- Prior art date
Links
- 244000060011 Cocos nucifera Species 0.000 title claims abstract description 77
- 235000013162 Cocos nucifera Nutrition 0.000 title claims abstract description 77
- 239000000284 extract Substances 0.000 title claims abstract description 75
- 201000004384 Alopecia Diseases 0.000 title claims abstract description 49
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 231100000360 alopecia Toxicity 0.000 title claims description 23
- 208000024963 hair loss Diseases 0.000 claims abstract description 24
- 230000000694 effects Effects 0.000 claims abstract description 18
- 230000003779 hair growth Effects 0.000 claims abstract description 17
- 230000003676 hair loss Effects 0.000 claims abstract description 17
- 230000001737 promoting effect Effects 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000002537 cosmetic Substances 0.000 claims description 12
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 claims description 9
- 230000036541 health Effects 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 235000013376 functional food Nutrition 0.000 claims description 7
- 230000003752 improving hair Effects 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 208000003024 Diffuse alopecia Diseases 0.000 claims description 2
- 208000004631 alopecia areata Diseases 0.000 claims description 2
- 206010068168 androgenetic alopecia Diseases 0.000 claims description 2
- 201000002996 androgenic alopecia Diseases 0.000 claims description 2
- 230000006872 improvement Effects 0.000 claims description 2
- 230000037390 scarring Effects 0.000 claims description 2
- 201000001297 telogen effluvium Diseases 0.000 claims description 2
- 230000000472 traumatic effect Effects 0.000 claims description 2
- 206010010356 Congenital anomaly Diseases 0.000 claims 1
- 208000006379 syphilis Diseases 0.000 claims 1
- 230000035784 germination Effects 0.000 abstract description 23
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 abstract description 18
- 229910052776 Thorium Inorganic materials 0.000 abstract description 18
- 210000004209 hair Anatomy 0.000 abstract description 10
- 229940105039 coconut extract Drugs 0.000 abstract description 2
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 230000001153 anti-wrinkle effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000003020 moisturizing effect Effects 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
- 230000002087 whitening effect Effects 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 14
- 210000001161 mammalian embryo Anatomy 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 235000013361 beverage Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 241000235070 Saccharomyces Species 0.000 description 4
- 239000003240 coconut oil Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 210000002257 embryonic structure Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000004761 scalp Anatomy 0.000 description 4
- 230000008591 skin barrier function Effects 0.000 description 4
- 238000003809 water extraction Methods 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- -1 ascorbic acid glucoside Chemical class 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000186012 Bifidobacterium breve Species 0.000 description 2
- 241001468229 Bifidobacterium thermophilum Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 241001123633 Galactomyces Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000186840 Lactobacillus fermentum Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 241000202221 Weissella Species 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 210000000442 hair follicle cell Anatomy 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229940012969 lactobacillus fermentum Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 238000000874 microwave-assisted extraction Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000006186 oral dosage form Substances 0.000 description 2
- 239000006201 parenteral dosage form Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000000899 pressurised-fluid extraction Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000453701 Galactomyces candidum Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 241000192132 Leuconostoc Species 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241000235072 Saccharomyces bayanus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000198063 Saccharomyces kudriavzevii Species 0.000 description 1
- 241000198072 Saccharomyces mikatae Species 0.000 description 1
- 241001123228 Saccharomyces paradoxus Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000186675 Weissella confusa Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 208000034557 congenital alopecia Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- ULULAZKOCFNOIM-UHFFFAOYSA-N hexyl 4-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(O)C=C1 ULULAZKOCFNOIM-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000003864 humus Substances 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 230000037317 transdermal delivery Effects 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
코코넛 추출물을 함유하는 피부 미백, 항주름, 또는 보습용 조성물에 관한 것으로, 일 양상에 따른 코코넛 하우스토리움(Coconut haustorium) 추출물 또는 발아 전 코코넛(Cocos nucifera) 배아 추출물은 5α-리덕타아제의 저해 활성을 나타낸 뿐만 아니라, 새로운 모발의 생성할 수 있어 탈모 예방, 개선, 또는 치료, 또는 발모 촉진을 위한 조성물에 유용하게 사용될 수 있는 효과가 있다. Skin whitening containing coconut extract, anti-wrinkle, moisturizing, or as for the composition of the coconut house thorium (Coconut haustorium) Extract before germination or coconut (Cocos nucifera) germ extract is re-5α- reductase inhibition activity of the kinase in accordance with an aspect In addition to showing, there is an effect that can be usefully used in a composition for preventing, improving, or treating hair loss, or promoting hair growth since it can generate new hair.
Description
코코넛 추출물을 함유하는 탈모 개선 또는 육모 촉진용 조성물에 관한 것이다. It relates to a composition for improving hair loss or promoting hair growth, containing coconut extract.
피부장벽은 죽은 각질세포와 세포간 지질로 구성되어 있고, 외부 자극으로부터 피부를 보호하며 피부에서 수분이 증발하는 것을 막아주는 피부 보호막으로서 피부건강에 핵심적인 기능을 담당한다. 즉, 체내에서 지나친 수분 방출을 막고 화학물질이나 미생물처럼 해로운 물질이 우리 몸 안으로 들어오는 것을 막아준다. 죽은 각질세포의 표면을 구성하는 각질세포 외피에는 세포간 지질의 안정성에 중요한 역할을 한다. 각질형성세포는 분화를 통해 각질화 과정을 통해 피부 장벽을 만든다. 피부장벽 기능은 노화가 진행되거나 외부 요소들에 의해 파괴될 수 있으며, 피부 장벽의 손상은 피부 수분량 감소와 주름을 일으킬 수 있다.The skin barrier is composed of dead keratinocytes and intercellular lipids, and plays a key function in skin health as a skin protective film that protects the skin from external stimuli and prevents moisture from evaporating from the skin. In other words, it prevents the release of excess moisture from the body and prevents harmful substances such as chemicals and microorganisms from entering our body. The keratinocyte envelope, which forms the surface of dead keratinocytes, plays an important role in the stability of intercellular lipids. Keratinocytes form the skin barrier through the process of keratinization through differentiation. The skin barrier function can be destroyed by aging or external factors, and damage to the skin barrier can lead to reduced skin moisture content and wrinkles.
탈모는 유전적, 환경적, 정신적 요소 등 다양한 요인으로 인해 두피의 모세혈관이 수축되면서 가려움 증세와 함께 두피조직으로부터 머리카락이 이탈되는 현상을 말하며, 이는 현대인들의 고민거리 중 하나이다. 이와 같은 탈모의 원인은 과도한 정신적 스트레스와 두뇌 노동 그리고 인스턴트화 된 식생활로 인하여 두피 내 원활하지 못한 혈액 순환과 모근 세포의 영양결핍 및 내분비순환계의 기능저하를 초래하여 사멸하는 모근 세포 수에 비해 생장하는 모근 세포의 수가 현격히 감소하여 성장기 중이라도 조기 탈모현상이 발생한다. Hair loss refers to a phenomenon in which capillaries in the scalp are contracted due to various factors such as genetic, environmental, and mental factors, resulting in itching and hair removal from the scalp tissue, which is one of the concerns of modern people. The causes of such hair loss are due to excessive mental stress, brain labor, and instant diet, which leads to poor blood circulation in the scalp, malnutrition of the hair follicle cells, and deterioration of the endocrine circulatory system. The number of hair follicle cells significantly decreases, leading to early hair loss even during the growth phase.
따라서 최근에는 천연물을 활용한 소재의 개발을 위한 연구가 활발히 진행되고 있으며 인체에 안전하면서도 탈모 개선 활성을 갖는 소재의 개발에 대한 요구가 증가하고 있다.Therefore, in recent years, research for the development of materials using natural products is actively being conducted, and there is an increasing demand for the development of materials that are safe for the human body and have an activity for improving hair loss.
일 양상은 코코넛 하우스토리움(Coconut haustorium) 추출물 또는 발아 전 코코넛(Cocos nucifera) 배아 추출물을 함유하는 탈모 예방, 개선, 또는 치료, 또는 발모 촉진을 위한 화장료 조성물을 제공하는 것이다. One aspect is to provide a cosmetic composition for preventing, improving, or treating hair loss, or promoting hair growth, containing a coconut haustorium extract or a pre-germination coconut ( Cocos nucifera) embryo extract.
다른 양상은 코코넛 하우스토리움(Coconut haustorium) 추출물 또는 발아 전 코코넛(Cocos nucifera) 배아 추출물을 함유하는 탈모 예방, 개선, 또는 치료, 또는 발모 촉진을 위한 피부 외용제를 제공하는 것이다. Another aspect is to provide a skin external preparation for preventing, improving, or treating hair loss, or promoting hair growth, containing a coconut haustorium extract or a pre-emergence coconut ( Cocos nucifera) embryo extract.
또 다른 양상은 코코넛 하우스토리움(Coconut haustorium) 추출물 또는 발아 전 코코넛(Cocos nucifera) 배아 추출물을 함유하는 탈모 예방, 개선, 또는 치료, 또는 발모 촉진을 위한 약학적 조성물을 제공하는 것이다. Another aspect is to provide a pharmaceutical composition for preventing, improving, or treating hair loss, or promoting hair growth, containing a coconut haustorium extract or a pre-emergence coconut ( Cocos nucifera) embryo extract.
또 다른 양상은 코코넛 하우스토리움(Coconut haustorium) 추출물 또는 발아 전 코코넛(Cocos nucifera) 배아 추출물을 함유하는 탈모 예방, 개선, 또는 치료, 또는 발모 촉진을 위한 건강기능식품 조성물을 제공하는 것이다. Another aspect is to provide a health functional food composition for preventing, improving, or treating hair loss, or promoting hair growth, containing a coconut haustorium extract or a pre-germination coconut ( Cocos nucifera) embryo extract.
일 양상은 코코넛 하우스토리움(Coconut haustorium) 추출물 또는 발아 전 코코넛(Cocos nucifera) 배아 추출물을 함유하는 탈모 예방, 개선, 또는 치료, 또는 발모 촉진을 위한 조성물을 제공하는 것이다. One aspect is to provide a composition for preventing, improving, or treating hair loss, or promoting hair growth, containing a coconut haustorium extract or a pre-emergence coconut ( Cocos nucifera) embryo extract.
본 명세서에서 "코코넛 하우스토리움(Coconut haustorium)"은 "발아 후 코코넛의 배아 또는 그의 일부분"과 상호 호환적으로 사용되고, 코코넛의 발아 동안 배아의 원위로부터 형성되는 스폰지 흡수성 조직(spongy absorbent tissue)를 의미할 수 있다. As used herein, "Coconut haustorium" is used interchangeably with "an embryo of a coconut or a portion thereof after germination", and refers to a sponge absorbent tissue formed from the distal end of the embryo during the germination of the coconut. It can mean.
본 명세서에서 용어 "유효성분" 또는 "유효량"은 질환, 장애 또는 병태, 또는 그의 하나 이상의 증상의 경감, 진행 억제 또는 예방에 충분한 본원에서 제공되는 발명을 실시하는 과정에서 이용되는 조성물의 임의의 양을 의미할 수 있다.As used herein, the term "active ingredient" or "effective amount" refers to any amount of a composition used in the practice of the invention provided herein sufficient to alleviate, inhibit or prevent progression of a disease, disorder or condition, or one or more symptoms thereof. Can mean
본 명세서에서 용어, "투여하는," "도포하는", 및 "도입하는"은 상호교환적으로 사용되고 일 구체예에 따른 조성물의 원하는 부위로의 적어도 부분적 국소화를 초래하는 방법 또는 경로에 의한 개체내로의 일 구체예에 따른 조성물의 배치를 의미할 수 있다.As used herein, the terms "administering," "applying", and "introducing" are used interchangeably and into a subject by a method or route that results in at least partial localization of a composition according to one embodiment to a desired site. It may mean the arrangement of the composition according to one embodiment of.
본 명세서에서 용어 "탈모(alopecia)"는 두피로부터 모발이 탈락하는 현상 또는 모발이 성기거나 가늘어지는 상태를 의미하며, "탈모 예방, 또는 개선"이라 함은 상술한 바와 같은 탈모를 예방하고 억제하는 것을 의미하고, "육모 촉진 또는 발모 촉진"이라 함은 새로운 모발의 생성 촉진뿐만 아니라 기존 모발이 건강하게 자라도록 하는 것을 의미한다. 상기 탈모는 원형 탈모증(Alopecia Areata), 유전성 안드로겐 탈모증(Androgenetic Alopecia), 휴지기 탈모증(Telogen Effluvium), 외상성 탈모증, 발모벽(Trichotillomania), 압박성 탈모증(Pressure Alopecia), 생장기 탈모증, 비강성 탈모증, 매독성 탈모증(Alopecia syphlltiac), 지루 탈모증(Alopecia seborrhecia), 증후성 탈모증, 반흔성 탈모증, 선천성 탈모증 중에서 선택된 하나 이상일 수 있다.As used herein, the term "alopecia" refers to a phenomenon in which hair is removed from the scalp or a condition in which the hair is thin or thin, and "preventing or improving hair loss" means preventing and suppressing hair loss as described above. It means, and "promoting hair growth or promoting hair growth" means not only promoting the generation of new hair, but also allowing existing hair to grow healthy. The hair loss is alopecia areata, hereditary androgenetic alopecia, telogen effluvium, traumatic alopecia, tricotillomania, pressure alopecia, growth stage alopecia, non-rigid alopecia, falconia. It may be one or more selected from toxic alopecia (Alopecia syphlltiac), seborrheic alopecia (Alopecia seborrhecia), symptomatic alopecia, scarring alopecia, and congenital alopecia.
상기 추출물은 물, 알콜, 예를 들면, C1-C6 알콜, 예를 들면, C1-C4 알콜 또는 이들의 혼합물을 용매로 하여 추출된 것일 수 있다. 상기 C1-C6 알콜은 메탄올, 에탄올, 프로판올, 이소프로판올, 1,3-프로판디올, 부탄올, 펜탄올, 헥산올 등일 수 있다. 상기 용매는 예를 들면, 물과 알콜의 혼합물 즉 알콜 수용액일 수 있다. 알콜 수용액의 알콜 농도는 1 내지 99.5 (v/v)%, 예를 들면, 10 내지 99.5 (v/v)%, 1 내지 70(v/v)%, 1 내지 40(v/v)%, 5 내지 25(v/v)%, 7 내지 20(v/v)%, 5 내지 25(v/v)%, 또는 10 내지 20(v/v)%일 수 있다. 상기 알콜 수용액은 에탄올 수용액일 수 있다. The extract may be extracted using water, alcohol, for example, C1-C6 alcohol, for example, C1-C4 alcohol, or a mixture thereof as a solvent. The C1-C6 alcohol may be methanol, ethanol, propanol, isopropanol, 1,3-propanediol, butanol, pentanol, hexanol, and the like. The solvent may be, for example, a mixture of water and alcohol, that is, an aqueous alcohol solution. The alcohol concentration of the aqueous alcohol solution is 1 to 99.5 (v/v)%, for example, 10 to 99.5 (v/v)%, 1 to 70 (v/v)%, 1 to 40 (v/v)%, 5 to 25 (v/v)%, 7 to 20 (v/v)%, 5 to 25 (v/v)%, or 10 to 20 (v/v)%. The aqueous alcohol solution may be an aqueous ethanol solution.
상기 추출은 상기 코코넛 하우스토리움 전체, 그 일부분, 또는 이들로부터 유래된 재료, 또는 발아 전 코코넛 배아에 대하여 상기 추출 용매를 3 내지 10 (부피/중량)배, 예를 들면, 3 내지 7 (부피/중량)배, 3 내지 5 (부피/중량)배, 5 내지 10 (부피/중량)배, 또는 4 내지 10배 첨가하는 것을 포함할 수 있다. 예를 들면, 상기 인동 또는 지황의 전초, 그 일부분, 또는 이들로부터 유래된 재료 1kg에 대하여 상기 추출 용매를 3 내지 10 L 첨가하는 것을 포함할 수 있다.The extraction is performed by 3 to 10 (vol/w) times, for example, 3 to 7 (vol/w), of the extraction solvent with respect to the whole, a part of the coconut, or a material derived therefrom, or a coconut embryo before germination. It may include adding weight) times, 3 to 5 (volume/weight) times, 5 to 10 (volume/weight) times, or 4 to 10 times. For example, it may include adding 3 to 10 L of the extraction solvent to 1 kg of the outpost of the phosphorus or rhubarb, a portion thereof, or a material derived therefrom.
상기 추출은 가온된 액체 추출, 가압된 액체 추출 (pressurized liquid extraction: PLE), 초음파 도움을 받은 추출 (microwave assisted extraction: MAE), 아임계 추출 (subcritical extraction: SE), 또는 이들의 조합에 의하여 수행될 수 있다. 상기 아임계 추출은 아임계 수추출 (subcritical water extraction: SWE)일 수 있다. 아임계 수추출은 초가열된 수추출 (superheated water extraction) 또는 가압된 열수 추출 (pressurized hot water extraction: PHWE)라고도 한다. 상기 가온된 액체 추출은 환류 추출일 수 있다. The extraction is performed by warmed liquid extraction, pressurized liquid extraction (PLE), microwave assisted extraction (MAE), subcritical extraction (SE), or a combination thereof. Can be. The subcritical extraction may be subcritical water extraction (SWE). Subcritical water extraction is also referred to as superheated water extraction or pressurized hot water extraction (PHWE). The heated liquid extraction may be reflux extraction.
상기 추출은 4 내지 70, 예를 들면, 4 내지 50, 4℃ 내지 40, 4℃ 내지 30, 10℃ 내지 70, 15℃ 내지 70, 20℃ 내지 70, 4℃ 내지 50, 10℃ 내지 50, 4℃ 내지 40, 4℃ 내지 30, 10℃ 내지 40, 10℃ 내지 35, 또는 10 내지 30에서 수행하는 것일 수 있다. 상기 추출 시간은 선택된 온도에 따라 달라질 수 있는데 1 시간 내지 2개월, 예를 들면, 1 시간 내지 1개월, 1 시간 내지 15일, 1 시간 내지 10일, 1 시간 내지 5일, 1 시간 내지 3일, 1 시간 내지 2일, 1 시간 내지 1일, 5 시간 내지 1개월, 5 시간 내지 15일, 5 시간 내지 10일, 5 시간 내지 5일, 5 시간 내지 3일, 5 시간 내지 2일, 5 시간 내지 1일, 10 시간 내지 1개월, 10 시간 내지 15일, 10 시간 내지 10일, 10 시간 내지 5일, 10 시간 내지 3일, 또는 10 시간 내지 2일일 수 있다. 상기 추출은 상기 용매 중에 코코넛 하우스토리움 전체, 그 일부분, 또는 이들로부터 유래된 재료, 또는 발아 전 코코넛 배아를 혼합하고 일정 시간 동안 방치하는 것을 포함할 수 있다. 상기 방치는 적당한 교반을 포함할 수 있다. 상기 추출은 1회 이상, 예를 들면, 1 내지 5회 반복될 수 있다. The extraction is 4 to 70, for example, 4 to 50, 4 to 40, 4 to 30, 10 to 70, 15 to 70, 20 to 70, 4 to 50, 10 to 50, It may be performed at 4°C to 40, 4°C to 30, 10°C to 40, 10°C to 35, or 10 to 30. The extraction time may vary depending on the selected temperature, for example, 1 hour to 2 months, for example, 1 hour to 1 month, 1 hour to 15 days, 1 hour to 10 days, 1 hour to 5 days, 1 hour to 3 days. , 1 hour to 2 days, 1 hour to 1 day, 5 hours to 1 month, 5 hours to 15 days, 5 hours to 10 days, 5 hours to 5 days, 5 hours to 3 days, 5 hours to 2 days, 5 It may be time to 1 day, 10 hours to 1 month, 10 hours to 15 days, 10 hours to 10 days, 10 hours to 5 days, 10 hours to 3 days, or 10 hours to 2 days. The extraction may include mixing the whole of the coconut Huis Thorium, a portion thereof, or a material derived therefrom, or a coconut embryo before germination in the solvent, and leaving it for a predetermined time. The standing may include suitable agitation. The extraction may be repeated one or more times, for example, 1 to 5 times.
상기 추출은 식물체 잔사 및 추출액을 여과 등의 알려진 방법에 의하여 분리할 수 있다. 상기 추출은 또한 얻어진 추출액으로부터 감압 농축과 같은 알려진 방법에 의하여 용매를 제거하는 것을 포함할 수 있다. 상기 추출은 또한 얻어진 추출물을 동결건조와 같은 건조에 의하여 건조 추출물을 제조하는 것을 포함할 수 있다. The extraction may be performed by separating plant residues and extracts by known methods such as filtration. The extraction may also include removing the solvent from the obtained extract by known methods such as concentration under reduced pressure. The extraction may also include preparing a dried extract by drying the obtained extract, such as lyophilization.
상기 조성물은 조성물 총 중량에 대하여 0.001 중량% 내지 80 중량%, 예를 들면, 0.01 중량% 내지 60 중량%, 0.01 중량% 내지 40 중량%, 0.01 중량% 내지 30 중량%, 0.01 중량% 내지 20 중량%, 0.01 중량% 내지 10 중량%, 0.01 중량% 내지 5 중량%, 0.05 중량% 내지 60 중량%, 0.05 중량% 내지 40 중량%, 0.05 중량% 내지 30 중량%, 0.05 중량% 내지 20 중량%, 0.05 중량% 내지 10 중량%, 0.05 중량% 내지 5 중량%, 0.1 중량% 내지 60 중량%, 0.1 중량% 내지 40 중량%, 0.1 중량% 내지 30 중량%, 0.1 중량% 내지 20 중량%, 0.1 중량% 내지 10 중량%, 또는 0.1 중량% 내지 5 중량%의 추출물을 함유하는 것일 수 있다. The composition is from 0.001% to 80% by weight based on the total weight of the composition, for example, from 0.01% to 60% by weight, from 0.01% to 40% by weight, from 0.01% to 30% by weight, from 0.01% to 20% by weight %, 0.01% to 10%, 0.01% to 5%, 0.05% to 60%, 0.05% to 40%, 0.05% to 30%, 0.05% to 20%, 0.05% to 10% by weight, 0.05% to 5% by weight, 0.1% to 60% by weight, 0.1% to 40% by weight, 0.1% to 30% by weight, 0.1% to 20% by weight, 0.1% by weight % To 10% by weight, or 0.1% to 5% by weight of the extract may be contained.
다른 구체예에 있어서, 상기 추출물은 발효 추출물일 수 있다. In another embodiment, the extract may be a fermented extract.
일 구체예에 있어서, 상기 발효는 탄소원을 함유하는 배지에서 30 내지 60℃에서 pH 6 내지 7에서 1일 내지 7일간 이루어지는 것일 수 있다. 일 구체예에 있어서, 상기 발효는 바실러스(Bacillus) 속, 스트렙토코커스(Streptococcus) 속, 락토코커스(Lactococcus) 속, 엔테로코커스(Enterococcus) 속, 락토바실러스(Lactobacillus) 속, 페디오코커스(Pediococcus) 속, 류코노스톡(Leuconostoc) 속, 바이셀라(Weissella) 속, 비피도박테리움(Bifidobacterium) 속, 사카로마이세스(Saccharomyce) 속 및 갈락토마이세스(Galactomyces) 속으로 이루어진 군에서 선택된 하나 이상의 균주로 발효된 것일 수 있다. 더욱 구체적으로, 상기 균주는, 균주는 락토바실러스 플란타룸(Lactobacillus plantarum), 락토바실러스 카제이(Lactobacillus casei), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 락토바실러스 퍼멘텀(Lactobacillus fermentum), 락토바실러스 커바투스(Lactobacillus curvatus), 락토바실러스 콘푸수스(Lactobacillus confusus), 락토바실러스 가세리(Lactobacillus gasseri), 비피도박테리움 브레브(Bifidobacterium breve), 비피도박테리움 써모필럼(Bifidobacterium thermophilum), 스트렙토코크스 써모필루스(Streptococcus thermophilus), 류코노스톡 메센테로이데스(Leuconostoc mesenteroides), 사카로마이세스 세레비지애(S. cerevisiae), 사카로마이세스 바야누스(S. bayanus), 사카로마이세스 파라독서스 (S. paradoxus), 사카로마이세스 미카테(S. mikatae), 사카로마이세스 쿠드리아브제비(S. kudriavzevii), 또는 갈락토마이세스 칸디둠(Galactomyces candidum)일 수 있다. In one embodiment, the fermentation may be performed for 1 to 7 days at pH 6 to 7 at 30 to 60° C. in a medium containing a carbon source. In one embodiment, the fermentation is Bacillus genus, Streptococcus genus, Lactococcus genus, Enterococcus genus, Lactobacillus genus, Pediococcus genus , Leukonostoc (Leuconostoc), Weissella (Weissella), Bifidobacterium (Bifidobacterium), Saccharomyces (Saccharomyce) and Galactomyces (Galactomyces) genus selected from the group consisting of one or more strains selected from the group consisting of It may be fermented. More specifically, the strain is Lactobacillus plantarum , Lactobacillus casei , Lactobacillus acidophilus , Lactobacillus fermentum , Lactobacillus fermentum Bacillus curvatus , Lactobacillus confusus , Lactobacillus gasseri , Bifidobacterium breve , Bifidobacterium breve, Bifidobacterium thermophilum (Bifidobacterium thermophilum) Streptococcus thermophilus , Leuconostoc mesenteroides , S. cerevisiae , S. bayanus , Saccharomyces para. reading can be one's (S. paradoxus), Saccharomyces access to US Mai category (S. mikatae), access to Sakae-ku My'll Havre lots (S. kudriavzevii), or galactose Mai Seth Kandy Doom (Galactomyces candidum).
특정 이론에 제한됨이 없이, 상기 코코넛 하우스토리움, 또는 발아전 코코넛 배아의 추출물(또는 발효 추출물)은 5α-리덕타아제의 활성을 억제하는 것일 수 있다. 따라서, 상기 조성물은 탈모 예방, 개선, 또는 치료, 또는 발모 촉진에 유용하게 사용될 수 있는 효과가 있다. Without being limited by a particular theory, the coconut haus thorium, or an extract (or fermented extract) of a coconut embryo before germination may be one that inhibits the activity of 5α-reductase. Accordingly, the composition has an effect that can be usefully used for preventing, improving, or treating hair loss, or promoting hair growth.
일 구체예에 있어서, 상기 조성물은 화장료 조성물일 수 있다. 상기 화장료 조성물은 예를 들면, 유연화장수, 영양화장수, 마사지크림, 영양크림, 에센스, 팩, 젤, 앰플 또는 피부 점착 타입의 화장료 제형을 갖는 것일 수 있다. 상기 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 조성물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 포함할 수 있다.In one embodiment, the composition may be a cosmetic composition. The cosmetic composition may be, for example, a softening lotion, a nutritional lotion, a massage cream, a nutritional cream, an essence, a pack, a gel, an ampoule, or a cosmetic formulation of a skin adhesion type. Ingredients included in the cosmetic composition may include ingredients commonly used in cosmetic compositions in addition to the composition as an active ingredient. For example, conventional adjuvants and carriers such as stabilizers, solubilizers, vitamins, pigments and fragrances It may include.
다른 구체예에 있어서, 상기 조성물을 피부 외용제 조성물일 수 있다. In another embodiment, the composition may be a composition for external application for skin.
상기 피부외용제는 크림, 겔, 연고, 피부 유화제, 피부 현탁액, 경피전달성 패치, 약물 함유 붕대, 로션, 또는 그 조합일 수 있다. 상기 피부외용제는 통상 화장품이나 의약품 등의 피부외용제에 사용되는 성분, 예를 들면 수성성분, 유성성분, 분말성분, 알코올류, 보습제, 증점제, 자외선흡수제, 미백제, 방부제, 산화방지제, 계면활성제, 향료, 색제, 각종 피부 영양제, 또는 이들의 조합과 필요에 따라서 적절하게 배합될 수 있다. 상기 피부외용제는, 에데트산이나트륨, 에데트산삼나트륨, 시트르산나트륨, 폴리인산나트륨, 메타인산나트륨, 글루콘산 등의 금속봉쇄제, 카페인, 탄닌, 벨라파밀, 감초추출물, 글라블리딘, 칼린의 과실의 열수추출물, 각종생약, 아세트산토코페롤, 글리틸리틴산, 트라넥삼산 및 그 유도체 또는 그 염등의 약제, 비타민 C, 아스코르브산인산마그네슘, 아스코르브산글루코시드, 알부틴, 코지산, 글루코스, 프룩토스, 트레할로스 등의 당류등도 적절하게 배합할 수 있다.The external preparation for skin may be a cream, a gel, an ointment, a skin emulsifier, a skin suspension, a transdermal delivery patch, a drug-containing bandage, a lotion, or a combination thereof. The above skin external preparations are ingredients commonly used in external preparations for skin such as cosmetics and pharmaceuticals, such as aqueous ingredients, oily ingredients, powder ingredients, alcohols, moisturizers, thickeners, ultraviolet absorbers, whitening agents, preservatives, antioxidants, surfactants, fragrances. , Colorants, various skin nutrients, or a combination thereof and may be appropriately formulated according to need. The external preparations for the skin include metal sequestering agents such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate, and gluconic acid, caffeine, tannin, bellapamil, licorice extract, glavidine, and caline. Hot-water extract of fruit, various herbal medicines, drugs such as tocopherol acetate, glytilithic acid, tranexamic acid and derivatives or salts thereof, vitamin C, ascorbic acid magnesium phosphate, ascorbic acid glucoside, arbutin, kojic acid, glucose, fructose, Sugars such as trehalose can also be appropriately blended.
다른 구체예에 있어서, 상기 조성물은 약학적 조성물일 수 있다. In another embodiment, the composition may be a pharmaceutical composition.
상기 약학적 조성물은 약제학적으로 허용가능한 희석제 또는 담체를 추가적으로 포함할 수 있다. 상기 희석제는 유당, 옥수수 전분, 대두유, 미정질 셀룰로오스, 또는 만니톨, 활택제로는 스테아린산 마그네슘, 탈크, 또는 그 조합일 수 있다. 상기 담체는 부형제, 붕해제, 결합제, 활택제, 또는 그 조합일 수 있다. 상기 부형제는 미결정 셀룰로오즈, 유당, 저치환도 히드록시셀룰로오즈, 또는 그 조합일 수 있다. 상기 붕해제는 카르복시메틸셀룰로오스 칼슘, 전분글리콜산 나트륨, 무수인산일수소 칼슘, 또는 그 조합일 수 있다. 상기 결합제는 폴리비닐피롤리돈, 저치환도 히드록시프로필셀룰로오즈, 히드록시프로필셀룰로오즈, 또는 그 조합일 수 있다. 상기 활택제는 스테아린산 마그네슘, 이산화규소, 탈크, 또는 그 조합일 수 있다. The pharmaceutical composition may additionally include a pharmaceutically acceptable diluent or carrier. The diluent may be lactose, corn starch, soybean oil, microcrystalline cellulose, or mannitol, and as a lubricant, magnesium stearate, talc, or a combination thereof. The carrier may be an excipient, a disintegrant, a binder, a lubricant, or a combination thereof. The excipient may be microcrystalline cellulose, lactose, low-substituted hydroxycellulose, or a combination thereof. The disintegrant may be calcium carboxymethylcellulose, sodium starch glycolate, anhydrous calcium monohydrogen phosphate, or a combination thereof. The binder may be polyvinylpyrrolidone, low-substituted hydroxypropylcellulose, hydroxypropylcellulose, or a combination thereof. The lubricant may be magnesium stearate, silicon dioxide, talc, or a combination thereof.
상기 약학적 조성물은 경구 또는 비경구 투여 제형으로 제형화될 수 있다. 경구 투여 제형은 과립제, 산제, 액제, 정제, 캅셀제, 건조시럽제, 또는 그 조합일 수 있다. 비경구 투여 제형은 주사제일 수 있다.The pharmaceutical composition may be formulated as an oral or parenteral dosage form. The oral dosage form may be a granule, a powder, a liquid, a tablet, a capsule, a dry syrup, or a combination thereof. The parenteral dosage form may be an injection.
다른 구체예에 있어서, 상기 조성물은 건강기능식품일 수 있다. 상기 건강기능식품 조성물은 일 구체예에 따른 코코넛 하우스토리움 추출물 또는 발아 전 코코넛 배아 추출물 단독 또는 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 사용 목적 (예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다. 일반적으로, 식품 또는 음료의 제조시에 본 명세서의 조성물은 원료에 대하여 15 중량부 이하의 양으로 첨가될 수 있다. 상기 건강기능식품의 종류에는 특별한 제한은 없다. 건강기능식품의 종류 중 음료 조성물은 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 건강식품 조성물은 또한 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제, 또는 그 조합을 함유할 수 있다. 상기 건강기능식품 조성물은 또한, 천연 과일쥬스, 과일쥬스 음료, 야채 음료의 제조를 위한 과육, 또는 그 조합을 함유할 수 있다.In another embodiment, the composition may be a health functional food. The health functional food composition may be used alone or with other foods or food ingredients, or may be appropriately used according to a conventional method, such as a coconut haus thorium extract or a coconut germ extract before germination according to an embodiment. The mixing amount of the active ingredient may be appropriately determined according to the purpose of use (prevention, health or therapeutic treatment). In general, when preparing food or beverage, the composition of the present specification may be added in an amount of 15 parts by weight or less based on the raw material. There is no particular limitation on the kind of the health functional food. Among the types of health functional foods, the beverage composition may contain various flavoring agents or natural carbohydrates as an additional component, like ordinary beverages. The natural carbohydrates are monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As the sweetener, natural sweeteners such as taumatin and stevia extract, and synthetic sweeteners such as saccharin and aspartame can be used. The health food composition may also be used in nutrients, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonated beverages. It may contain a carbonation agent to be used, or a combination thereof. The health functional food composition may also contain natural fruit juice, fruit juice beverage, pulp for the production of vegetable beverages, or a combination thereof.
일 양상에 따른 코코넛 하우스토리움(Coconut haustorium) 추출물 또는 발아 전 코코넛(Cocos nucifera) 배아 추출물은 5α-리덕타아제의 저해 활성을 나타낸 뿐만 아니라, 새로운 모발의 생성할 수 있어 탈모 예방, 개선, 또는 치료, 또는 발모 촉진을 위한 조성물에 유용하게 사용될 수 있는 효과가 있다. Coconut Haustorium (Coconut haustorium) extract according to one aspect or the Cocos nucifera embryo extract before germination shows the inhibitory activity of 5α-reductase, as well as the generation of new hair, preventing, improving, or treating hair loss. , Or there is an effect that can be usefully used in a composition for promoting hair growth.
이하 본 발명을 실시예를 통하여 보다 상세하게 설명한다. 그러나, 이들 실시예는 본 발명을 예시적으로 설명하기 위한 것으로 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다. Hereinafter, the present invention will be described in more detail through examples. However, these examples are for illustrative purposes only, and the scope of the present invention is not limited to these examples.
실시예 1. 발아 후 코코넛 배아(코코넛 하우스토리움) 추출물의 제조Example 1. Preparation of Coconut Germ (Coconut Haus Thorium) Extract after Germination
발아 후 코코넛 배아(코코넛 하우스토리움) 추출물은 다음과 같이 제조하였다. After germination, a coconut germ (coconut haus thorium) extract was prepared as follows.
먼저, 발아된 코코넛(바누아트산 직접 수입)으로부터 배아(코코넛 하우스토리움)를 분리하였다. 약 100 g의 코코넛 하우스토리움을 분리한 이후에, 이들을 분쇄한 후, 물 200 ㎖을 각각 첨가하여 상온에서 48 시간 교반한 후 추출하였다. 추출 후 여과지(filter paper;Whatman NO. 2, Maidstone, UK)로 여과하여 40 ℃ 이하의 중탕에서 감압 환류 냉각장치(N-1110S, EYELA, Tokyo, JAPAN)로 농축한 후 동결건조하였다. 모든 시료는 실험 전까지 80 ℃ 냉동 보관하였으며, 디메틸설폭사이드(dimethyl sulfoxide, DMSO)에 용해하여 실험에 사용하였다. 회수율은 17.89% 이었다. First, embryos (Coconut House Thorium) were isolated from germinated coconuts (directly imported from Vanuat). After separating about 100 g of coconut haus thorium, they were pulverized, 200 ml of water was added, and the mixture was stirred at room temperature for 48 hours, followed by extraction. After extraction, it was filtered with filter paper (Whatman NO. 2, Maidstone, UK), concentrated with a reduced pressure reflux cooling device (N-1110S, EYELA, Tokyo, Japan) in a water bath of 40° C. or lower, and then freeze-dried. All samples were stored frozen at 80 °C until the experiment, dissolved in dimethyl sulfoxide (DMSO) and used in the experiment. The recovery rate was 17.89%.
실시예 2. 발아 전 코코넛 배아 추출물의 제조 Example 2. Preparation of coconut germ extract before germination
먼저, 발아되기 전의 코코넛(바누아트산 직접 수입)으로부터 배아를 분리하였다. 약 100 g의 코코넛 배아를 분리한 이후에, 이들을 분쇄한 후, 물 200 ㎖을 각각 첨가하여 상온에서 48 시간 교반한 후 추출하였다. 추출 후 여과지(filter paper;Whatman NO. 2, Maidstone, UK)로 여과하여 40 ℃ 이하의 중탕에서 감압 환류 냉각장치(N-1110S, EYELA, Tokyo, JAPAN)로 농축한 후 동결건조하였다. 모든 시료는 실험 전까지 80 ℃ 냉동 보관하였으며, 디메틸설폭사이드(dimethyl sulfoxide, DMSO)에 용해하여 실험에 사용하였다. 회수율은 19.21% 이었다. First, embryos were isolated from coconuts (directly imported from Vanuat) before germination. After separating about 100 g of coconut embryos, they were pulverized, and then 200 ml of water were each added, stirred at room temperature for 48 hours, and then extracted. After extraction, it was filtered with filter paper (Whatman NO. 2, Maidstone, UK), concentrated with a reduced pressure reflux cooling device (N-1110S, EYELA, Tokyo, Japan) in a water bath of 40° C. or lower, and then freeze-dried. All samples were stored frozen at 80 °C until the experiment, dissolved in dimethyl sulfoxide (DMSO) and used in the experiment. The recovery rate was 19.21%.
실시예 3. 발아 후 코코넛 배아(코코넛 하우스토리움) 발효 추출물의 제조 Example 3. Preparation of fermented extract of coconut germ (coconut hausthorium) after germination
먼저, 발아된 코코넛(바누아트산 직접 수입)으로부터 배아(코코넛 하우스토리움)를 분리하였다. Saccharomyces cerevisiae을 YM 고체 배지에서 37℃ 온도로 24시간 활성화시킨 후, 형성된 콜로니를 멸균된 YM 액체 배지에 접종한 후 25℃ 내지 50℃ 온도 배양기에서 24시간 진탕배양시켰다. 이후에, 상기 분쇄된 코코넛 하우스토리움을 10 g/L가 되도록 균주 배양액에 첨가한 후, 37 ℃에서 1 내지 3일간 배양하였다. 이후에, 발효를 종료하기 위해 100℃에서 40분간 열을 가하여 균의 기능상실을 유도하였다. 원심분리기를 이용하여 침전물을 제거하고 상등액을 채취하거나, 여과된 상등액을 사용하였다. 제조된 발효액은 동물세포 배양용 배지인 MEM과 동량으로 섞은 후에 0.22 ㎛ 필터에 여과하여 균을 제거한 액을 사용하였다. First, embryos (Coconut House Thorium) were isolated from germinated coconuts (directly imported from Vanuat). After activating Saccharomyces cerevisiae in YM solid medium at 37°C for 24 hours, the formed colonies were inoculated in sterilized YM liquid medium and then cultured with shaking in a temperature incubator at 25°C to 50°C for 24 hours. Thereafter, the crushed coconut Haus Thorium was added to the strain culture solution to a concentration of 10 g/L, and then cultured at 37° C. for 1 to 3 days. Thereafter, in order to terminate the fermentation, heat was applied at 100° C. for 40 minutes to induce a loss of function of the bacteria. The precipitate was removed using a centrifuge and the supernatant was collected, or the filtered supernatant was used. The prepared fermentation broth was mixed in the same amount with MEM, an animal cell culture medium, and then filtered through a 0.22 μm filter to remove bacteria.
실험예 1. 코코넛 배아 추출물의 5α-리덕타아제 활성 억제력 분석Experimental Example 1. Analysis of 5α-reductase activity inhibitory ability of coconut germ extract
상기 실시예 1 및 2에서 제조한 코코넛 하우스토리움 추출물과 발아 전 코코넛 배아 추출물의 탈모 개선 활성을 분석하기 위해 5α-리덕타아제 활성 저해 효과를 측정하였다. In order to analyze the hair loss improvement activity of the coconut haus thorium extract prepared in Examples 1 and 2 and the coconut germ extract before germination, the inhibitory effect of 5α-reductase activity was measured.
구체적으로, Tris-HCL 완충액(pH 7.2) 1.0ml, 테스토스테론 (500ug/ml) 0.3 ml 및 효소액 1.0 ml를 혼합하고, 상기 실시예 1 내지 3에서 제조한 추출물을 각각 50, 100, 및 200 ug/ml의 농도로 추가하였다. 이후에, NADPH (0.77mg/ml) 0.5ml을 가하여 반응을 개시하고, 37℃ 에서 30분간 배양 하였다. 디클로로메탄(Dichloromethane) 5ml을 첨가하여 반응을 정지시켰다. 다음에, 내부 표준물질 (p-hydroxybenzoicacid n-hexyl ester, 0.1mg/ml) 0.5ml을 가하여 10분간 진탕하고, 3000rpm에서 10분간 원심분리 하였다. 다음으로 상층을 제거하고 남은 디클로로메탄층에 메탄올 5ml을 가하여 고속 액체크로마토그래피(HPLC)용 샘플로 사용하였다. 대조군으로는 NADPH를 가하기 전에 디클로로메탄을 첨가하여 반응을 일으키지 않도록 한 것을 사용하였고, 비교군으로는 동일 용량의 코코넛 오일 및 코코넛 열매 추출물을 사용하였다. 코코넛 열매 추출물은 코코넛의 Kernel 부위를 분리한 후, 상기 실시예 1과 동일한 방법으로 제조하였다. 대조군 대비 효소 저해 활성은 하기 표 1에 나타내었다. Specifically, 1.0 ml of Tris-HCL buffer (pH 7.2), 0.3 ml of testosterone (500 ug/ml), and 1.0 ml of enzyme solution were mixed, and the extracts prepared in Examples 1 to 3 were respectively 50, 100, and 200 ug/ It was added to a concentration of ml. Thereafter, 0.5ml of NADPH (0.77mg/ml) was added to initiate the reaction, followed by incubation at 37°C for 30 minutes. The reaction was stopped by adding 5 ml of dichloromethane. Next, 0.5ml of an internal standard (p-hydroxybenzoicacid n-hexyl ester, 0.1mg/ml) was added, shaken for 10 minutes, and centrifuged at 3000rpm for 10 minutes. Next, the upper layer was removed, and 5 ml of methanol was added to the remaining dichloromethane layer, which was used as a sample for high-speed liquid chromatography (HPLC). As a control group, dichloromethane was added before adding NADPH to prevent a reaction, and as a control group, the same amount of coconut oil and coconut fruit extract were used. Coconut fruit extract was prepared in the same manner as in Example 1 after separating the kernel portion of the coconut. The enzyme inhibitory activity compared to the control is shown in Table 1 below.
CH 추출물: 코코넛 하우스토리움 추출물; CB 추출물: 발아전 코코넛 배아 추출물; CO: 코코넛 오일; CN 추출물: 코코넛 열매 추출물CH extract: Coconut Huisthorium extract; CB extract: pre-emergence coconut germ extract; CO: coconut oil; CN Extract: Coconut Fruit Extract
상기 표 1에 나타낸 바와 같이, 일 구체예에 따른 코코넛 하우스토리움 추출물 또는 발아 전 코코넛 배아 추출물은 농도 의존적으로 5α-리덕타아제의 활성을 억제함을 알 수 있었다. 이에 반해 비교군인 코코넛 오일은 5α-리덕타아제의 활성 억제 효과가 거의 없고, 코코넛 하우스토리움 추출물은 코코넛 오일에 비해 약 5배 내지 6배 이상의 효과가 있는 것을 알 수 있었다. 이러한 결과는, 일 구체예에 따른 코코넛 하우스토리움 추출물 또는 발아 전 코코넛 배아 추출물이 탈모를 유발하는 남성 호르몬인 디하이드로테스토스테론(dihydrotestosterone)생성을 촉진하는 5α-리덕타아제를 저해하여 탈모의 예방 또는 개선에 유용하게 사용될 수 있음을 의미한다. As shown in Table 1, it was found that the coconut haus thorium extract or the coconut germ extract before germination according to one embodiment inhibited the activity of 5α-reductase in a concentration-dependent manner. On the other hand, it was found that coconut oil, which is a comparative group, has little effect of inhibiting the activity of 5α-reductase, and the coconut Huis Thorium extract has an effect of about 5 to 6 times more than that of coconut oil. These results show that the coconut haus thorium extract or the coconut embryo extract before germination according to an embodiment inhibits 5α-reductase, which promotes the production of dihydrotestosterone, a male hormone that causes hair loss, to prevent or improve hair loss. It means that it can be used usefully.
실험예 2. 코코넛 배아 추출물의 발모 효과 인 비보(Experimental Example 2. Vivo, which is the hair growth effect of coconut germ extract ( in vivoin vivo ) 분석) analysis
상기 실시예 1 및 2에서 제조한 코코넛 하우스토리움 추출물과 발아 전 코코넛 배아 추출물이 인 비보(in vivo)에서 활성을 나타내는지 분석하기 위해 마우스 모델을 사용하였다. A mouse model was used to analyze whether the coconut humus thorium extract prepared in Examples 1 and 2 and the coconut germ extract before germination exhibited activity in vivo.
구체적으로, 약 5-6주령의 마우스(C57BL/6, OrientBio) 총 6마리를 사용하여 등 부위 털을 제거하고 상기 제조된 코코넛 하우스토리움 추출물과 발아 전 코코넛 배아 추출물 200 ug/ml을 각 3마리씩 1일 1회 4주간 도포하였다. 털을 제거한 면적대비 신생모가 자란 면적의 비율을 디지털카메라(Japan, olympia)로 촬영하고 이미지화상 분석기(Image analyzer/Image-Pro Plus, U.S.A)를 이용하여 비교하였고, 그 결과를 하기 표 2에 나타내었다. Specifically, a total of 6 mice (C57BL/6, OrientBio) of about 5-6 weeks old were used to remove the hair on the back, and each of the prepared coconut Huis Thorium extract and the coconut germ extract 200 ug/ml before germination were added to each of 3 mice. It was applied once a day for 4 weeks. The ratio of the area grown by the new hair to the area from which the hair was removed was photographed with a digital camera (Japan, olympia) and compared using an image analyzer (Image analyzer/Image-Pro Plus, USA), and the results are shown in Table 2 below. I got it.
면적비(%)Hair-regrown area/shaved area
Area ratio (%)
CH 추출물: 코코넛 하우스토리움 추출물; CB 추출물: 발아전 코코넛 배아 추출물CH extract: Coconut Huisthorium extract; CB extract: Coconut germ extract before germination
상기 표 2에 나타낸 바와 같이, 일 구체예에 따른 코코넛 하우스토리움 추출물 또는 발아 전 코코넛 배아 추출물은 현저한 발모 효과가 있으며, 특히 코코넛 하우스토리움 추출물은 발아 전 코코넛 배아 추출물과 비교하여서도 약 1.5 배 정도의 현저한 효과가 있음을 알 수 있었다. As shown in Table 2, the coconut huis thorium extract or the coconut germ extract before germination according to one embodiment has a remarkable hair growth effect, and in particular, the coconut huis thorium extract is about 1.5 times as much as the coconut germ extract before germination. It was found that there was a remarkable effect.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190069559A KR102249431B1 (en) | 2019-06-12 | 2019-06-12 | Composition for treating alopecia comprising Cocos nucifera extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190069559A KR102249431B1 (en) | 2019-06-12 | 2019-06-12 | Composition for treating alopecia comprising Cocos nucifera extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200142377A KR20200142377A (en) | 2020-12-22 |
KR102249431B1 true KR102249431B1 (en) | 2021-05-07 |
Family
ID=74086572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190069559A KR102249431B1 (en) | 2019-06-12 | 2019-06-12 | Composition for treating alopecia comprising Cocos nucifera extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102249431B1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100849678B1 (en) * | 2006-06-28 | 2008-08-01 | 주식회사 정식품 | Extracts of soy hypocotyl with effects on skin whitening and composition comprising the same |
KR101750524B1 (en) * | 2015-07-22 | 2017-06-23 | 김일태 | Cream-type cosmetic composition containing velvet-extract |
KR101765856B1 (en) * | 2015-07-22 | 2017-08-23 | 주식회사 디앤허브 | Cleansing cosmetic composition containing velvet-extract |
KR101750522B1 (en) * | 2015-07-22 | 2017-06-23 | 김일태 | Essence cosmetic composition containing velvet-extract |
KR101945981B1 (en) * | 2018-06-07 | 2019-02-08 | (주)아모레퍼시픽 | Skin external composition comprising germinated Camellia sinensis seed extract |
-
2019
- 2019-06-12 KR KR1020190069559A patent/KR102249431B1/en active IP Right Grant
Non-Patent Citations (1)
Title |
---|
네이버 블로그(https://blog.naver.com/floraia_kelly/221494236123): 코코넛샴푸 천연계면활성제샴푸 에브라임 코코넛샴푸/감성먹거리 케이티바이오팜 (2019.03.22.)* |
Also Published As
Publication number | Publication date |
---|---|
KR20200142377A (en) | 2020-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20190020946A (en) | A composition for preventing or improving skin wrinkle comprising herb extracts or fermentation products thereof | |
CN112438921B (en) | Composition for improving skin beauty comprising fermented notoginseng root extract obtained from aspergillus guaneus | |
KR102484422B1 (en) | Cosmetic composition comprising extract of Cactus and fermented product of Lactobacillus | |
KR102560091B1 (en) | Novel Scalp-derived Lacticaseibacillus rhamnosus sc.Q5 strain having antibacterial effect against hair loss-inducing harmful bacteria and hair loss prevention activity and use thereof | |
KR102578892B1 (en) | Cosmetic composition comprising a fermented product obtained by fermenting a plant extract using a Bacillus stain | |
KR20180114783A (en) | Composition for improving skin beauty comprising extract of fermented soybean fermented with Aspergillus cristatus strain | |
KR102599144B1 (en) | Composition comprising an extract of Ganoderma lucidum for improving hair or scalp condition | |
US20170135948A1 (en) | Composition comprising extract of autumn soybean leaves | |
KR102249431B1 (en) | Composition for treating alopecia comprising Cocos nucifera extract | |
KR102249430B1 (en) | Composition for whitening, anti-wrinkle or moisturizing comprising Cocos nucifera extract | |
KR102467931B1 (en) | Brevibacillus borstelensis strain and its use for improving hair or scalp condition | |
KR102249432B1 (en) | Composition for preventing or treating skin inflammation comprising Cocos nucifera extract | |
KR102176883B1 (en) | Composition for skin regeneration, anti-wrinkle, or wound healing containing Prunus persica resin | |
KR102495405B1 (en) | Micrococcus luteus strain and its use for improving hair or scalp condition | |
KR102224313B1 (en) | Composition for skin whitening comprising scutellaria alpina extract | |
KR101994618B1 (en) | A composition for skin smoothing comprising an extract of fermented ponciri fructus | |
KR102495404B1 (en) | Brevundimonas vesicularis strain and its use for improving hair or scalp condition | |
KR102687359B1 (en) | Novel Scalp-derived Lacticaseibacillus rhamnosus sc.Q5 strain having hair growth promotion effect and use thereof | |
KR102495402B1 (en) | Burkholderia vietnamiensis strain and its use for improving hair or scalp condition | |
KR102480528B1 (en) | Streptococcus pneumoniae strain and its use for improving hair or scalp condition | |
KR102691626B1 (en) | Enhydrobacter aerosaccus V-5 strain and its use for improving skin conditions | |
KR102480527B1 (en) | Kocuria palustris strain and its use for improving hair or scalp condition | |
KR20230131504A (en) | Composition comprising microorganism fermented oil of traditional herbal medicines and its use for improving skin condition | |
KR20220096075A (en) | Novosphingobium humi strain and its use for improving hair or scalp condition | |
KR20230151776A (en) | Composition for anti-inflammatory, anti-oxidation and anti-allergy comprising Udo- Houttunynica cordata |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |